Skip to content

low haemoglobin with recurrent allergic rhinitis

An analytical study of low haemoglobin level in association with recurrent allergic rhinitis with intervention - nil

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055342
Enrollment
100
Registered
2023-07-19
Start date
Unknown
Completion date
Unknown
Last updated
2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: J309- Allergic rhinitis, unspecified

Interventions

Intervention1: Homoeopathic Similimum: Potentised homoeopathic medicine which is similimun is used in the form of pills or powder. Dose: The final selected remedy based on the individual totality will

Sponsors

Self
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Samples of all sexes of all age groups with the case definition. 2. Diagnostic criteria are mainly based on Hb level 3. Patients having complaints of recurrent allergic rhinitis at least for 12 months 4. Patients who are willing to sign a consent form

Exclusion criteria

Exclusion criteria: 1. Cases associated with systemic disorders and complications are excluded 2. Lactating and pregnant women are excluded 3. Individuals are excluded from the study if Hb is below or equal to 5%

Design outcomes

Primary

MeasureTime frame
1. To investigate the assocition between low Hb and allergic rhinitisTimepoint: The study is assessed based on the follow up taken according to patient for 8 weeks

Secondary

MeasureTime frame
1. To evaluate the Hb level of individual in early stages 2. To investigate the correlation between low Hb count and allergic rhinitisTimepoint: The study will be completed in 12-36 months.

Countries

India

Contacts

Public ContactDrSheetal Ajit Patil

Bharati vidyapeeth (DTU) HMC Pune satara road Dhanakawadi, Pune-43

Sheetal.patil@bharatividyapeeth.edu9850545835

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026